Dolby Laboratories (DLB) Tops Q3 EPS by 33c, Offers Guidance

Dolby Laboratories (NYSE: DLB) reported Q3 EPS of $0.68, $0.33 better than the analyst estimate of $0.35. Revenue for the quarter came in at $289.6 million versus the consensus estimate of $295.65 million.

GUIDANCE:

Dolby Laboratories sees Q4 2022 EPS of $0.68-$0.83, versus the consensus of $0.87. Dolby Laboratories sees Q4 2022 revenue of $295-325 billion, versus the consensus of $326.8 billion.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
• Etsy upgraded to buy at BofA on durable growth, buyback potential